Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer.

Okines, Alicia F C

Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer. [electronic resource] - Therapeutic advances in gastroenterology Sep 2012 - 301-18 p. digital

Publication Type: Journal Article

1756-2848

10.1177/1756283X12450246 doi